Medical News

RSS

Obesity linked to early puberty in girls

A review of more than 100 studies found overweight girls tend to reach puberty earlier than their peers do.

26 Jul 2010

Yayi International anticipates 66.7% increase in revenues for fiscal first-quarter

Yayi International Inc.,, the first mover and a leading producer and distributor of premium goat milk formula products for infants, toddlers, young children, and adults in the People's Republic of China, today announced that the Company expects to report strong sequential growth in the first quarter of its new fiscal year ended June 30, 2010.

26 Jul 2010

St. John Providence Health System to migrate to eClinicalWorks comprehensive EHR solution

eClinicalWorks®, a market leader in ambulatory clinical systems, today announced that St. John Providence Health System, the largest provider of inpatient care in southeast Michigan, will be offering eClinicalWorks comprehensive electronic health record (EHR) solution for its approximately 3,000 employed and affiliated physicians.

26 Jul 2010

FDA approves Perrigo's OTC Cetirizine Cherry Syrup

Perrigo Company today announced that it has received final approval from the U.S. Food and Drug Administration to manufacture and market over-the-counter (OTC) Cetirizine Cherry Syrup, 1mg/ml. Shipments will begin in the Company's fiscal first quarter 2011. Cherry joins the currently available grape flavor cetirizine syrup in Perrigo's product portfolio, giving patients a choice of store brand flavors.

26 Jul 2010

Colorcon acquires business of Pharmaceutical Coatings

Colorcon, Inc. today announced the acquisition of the business of Pharmaceutical Coatings Pvt. Ltd. (India) which includes the company's full product portfolio, plus a new facility in Goa that is currently under construction.

26 Jul 2010

KHN column: Where are the innovators in health care delivery?

In his latest Kaiser Health News column, John Goodman writes: "Almost everyone believes there is an enormous amount of waste and inefficiency in health care.

26 Jul 2010

Common myths around drinking

There are so many stories around alcohol and drinking that it's hard to know what to believe.

26 Jul 2010

Harco announces contract to manufacture MediGLIDER products for ConMediSys

Harco Metal Products (Harco), an industry leader in tube fabrication, systems integration, and seamless, cost effective manufacturing, announced today the contract to manufacture MediGLIDER™ products for ConMediSys.

26 Jul 2010

KIKA Clinical Solutions reports 47% increase in service bookings during first-half of 2010

KIKA™ Clinical Solutions is on track for unprecedented 2010 growth. KIKA is the leading provider of advanced EDC solutions for Clinical Asset Management™ for the pharmaceutical, biotechnology and medical device markets.

26 Jul 2010

Calibra Medical's Finesse insulin patch-pen receives FDA clearance for use with Novo Nordisk's Novolog

Calibra Medical announced today it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Finesse™ insulin patch-pen for up to three-day use with Novo Nordisk's Novolog® rapid acting insulin. Combining the mealtime therapy-adherence benefits of insulin pumps with the simplicity and affordability of syringes and pens, Calibra's novel bolus-only patch-pen is a small, adhesively attached, flat device that can be operated discretely through clothing to deliver mealtime, snack time, and correction bolus insulin in seconds.

26 Jul 2010

Intuit combines Medfusion with Quicken Health Group

Intuit Inc. has transformed its healthcare business by combining newly acquired Medfusion with its Quicken Health Group to create a new business unit called Intuit Health. Based in Cary, N.C., the group is committed to improving healthcare through innovative online connected services that make the clinical, administrative, and financial side of healthcare easier for everyone.

26 Jul 2010

Gilead Sciences announces $2.2 billion convertible senior notes offering

Gilead Sciences, Inc. today announced its intention to offer, subject to market and other conditions, approximately $1.1 billion principal amount of convertible senior notes due 2014 and approximately $1.1 billion principal amount of convertible senior notes due 2016 to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.

26 Jul 2010

Tibotec submits NDA for TMC278 anti-HIV compound to FDA

Tibotec Pharmaceuticals today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for TMC278 (rilpivirine), an investigational non-nucleoside reverse transcriptase inhibitor (NNRTI), being studied for once-daily use with other antiretroviral agents in treatment-naive HIV-1-infected adults. If approved, TMC278 will be the third anti-HIV compound to be introduced by Tibotec Pharmaceuticals.

26 Jul 2010

Insight Imaging acquires eight imaging centers

InSight Health Services Holdings Corp. today announced that it had completed the previously announced acquisition of eight imaging centers in the Phoenix, Arizona, El Paso, Texas, and Las Cruces, New Mexico areas from subsidiaries of MedQuest, Inc. and Novant Health, Inc.

26 Jul 2010

FDA grants Biovest's BiovaxID vaccine Orphan Drug Designation for mantle cell lymphoma

Biovest International, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to BiovaxID®, Biovest's personalized cancer vaccine, for a second lymphoma indication: mantle cell lymphoma. Mantle cell lymphoma is an aggressive and lethal B-cell blood cancer for which there is no current consensus standard-of-care.

26 Jul 2010

Boston Scientific launches Neuroform EZ Stent System

Boston Scientific Corporation today announced the U.S. and European launches of the Neuroform EZ™ Stent System, its fourth-generation intracranial aneurysm stent system designed for use in conjunction with endovascular coiling to treat wide-necked aneurysms. The Company plans to launch the product immediately in both markets.

26 Jul 2010

AVEO's initiation of AV-299 Phase 2 trial for lung cancer triggers $750,000 milestone payment to XOMA

XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced receipt of a $750,000 milestone payment under its collaboration with AVEO Pharmaceuticals, Inc.. The milestone payment resulted from AVEO's recent initiation of a Phase 2 clinical trial to evaluate its AV-299 antibody for the treatment of non-small cell lung cancer. AV-299 is a humanized antibody to hepatocyte growth factor (HGF).

26 Jul 2010

Researchers discover potential method for neurodegenerative disease detection

New investigations, initiated by research workers at CIC bioGUNE and led by Dr. Aitor Hierro, have opened possibilities for making progress in the knowledge and prediction of neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS), according to the journal of The Proceedings of the National Academy of Sciences of the United States of America.This study opens the possibility of research in humans to detect this pathology before the symptoms arise.

26 Jul 2010

Orthovita's PMA supplement for new collagen processing facility receives FDA approval

Orthovita, Inc., an orthobiologics and biosurgery company, reported today that the U.S. Food and Drug Administration (FDA) approved Orthovita's PMA supplement for a new collagen processing facility in Malvern, Pennsylvania. Orthovita will use the new facility to process the highly purified form of collagen used in its VITAGEL™ Surgical Hemostat product. VITAGEL is a composite liquid hemostat used in surgical procedures as an adjunct to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical.

26 Jul 2010

Onyx reports positive results from carfilzomib Phase 2b 003-A1 study in multiple myeloma

Onyx Pharmaceuticals, Inc. today announced positive top-line results from the Phase 2b 003-A1 study of single-agent carfilzomib, a selective, next generation proteasome inhibitor, in patients with relapsed and refractory multiple myeloma.

26 Jul 2010

Medical News

Obesity linked to early puberty in girls

Yayi International anticipates 66.7% increase in revenues for fiscal first-quarter

St. John Providence Health System to migrate to eClinicalWorks comprehensive EHR solution

FDA approves Perrigo's OTC Cetirizine Cherry Syrup

Colorcon acquires business of Pharmaceutical Coatings

KHN column: Where are the innovators in health care delivery?

Common myths around drinking

Harco announces contract to manufacture MediGLIDER products for ConMediSys

KIKA Clinical Solutions reports 47% increase in service bookings during first-half of 2010

Calibra Medical's Finesse insulin patch-pen receives FDA clearance for use with Novo Nordisk's Novolog

Intuit combines Medfusion with Quicken Health Group

Gilead Sciences announces $2.2 billion convertible senior notes offering

Tibotec submits NDA for TMC278 anti-HIV compound to FDA

Insight Imaging acquires eight imaging centers

FDA grants Biovest's BiovaxID vaccine Orphan Drug Designation for mantle cell lymphoma

Boston Scientific launches Neuroform EZ Stent System

AVEO's initiation of AV-299 Phase 2 trial for lung cancer triggers $750,000 milestone payment to XOMA

Researchers discover potential method for neurodegenerative disease detection

Orthovita's PMA supplement for new collagen processing facility receives FDA approval

Onyx reports positive results from carfilzomib Phase 2b 003-A1 study in multiple myeloma

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Latest News